| 000 | 01609 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250515210122.0 | ||
| 264 | 0 | _c20101207 | |
| 008 | 201012s 0 0 eng d | ||
| 022 | _a1569-8041 | ||
| 024 | 7 |
_a10.1093/annonc/mdq039 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aItaliano, A | |
| 245 | 0 | 0 |
_aClinical outcome of leiomyosarcomas of vascular origin: comparison with leiomyosarcomas of other origin. _h[electronic resource] |
| 260 |
_bAnnals of oncology : official journal of the European Society for Medical Oncology _cSep 2010 |
||
| 300 |
_a1915-1921 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 | _aCohort Studies |
| 650 | 0 | 4 | _aCombined Modality Therapy |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLeiomyosarcoma _xmortality |
| 650 | 0 | 4 |
_aLiver Neoplasms _xmortality |
| 650 | 0 | 4 |
_aLung Neoplasms _xmortality |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aRadiotherapy Dosage |
| 650 | 0 | 4 | _aSurvival Rate |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aVascular Neoplasms _xmortality |
| 700 | 1 | _aToulmonde, M | |
| 700 | 1 | _aStoeckle, E | |
| 700 | 1 | _aKind, M | |
| 700 | 1 | _aKantor, G | |
| 700 | 1 | _aCoindre, J-M | |
| 700 | 1 | _aBui, B | |
| 773 | 0 |
_tAnnals of oncology : official journal of the European Society for Medical Oncology _gvol. 21 _gno. 9 _gp. 1915-1921 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1093/annonc/mdq039 _zAvailable from publisher's website |
| 999 |
_c19537052 _d19537052 |
||